Ophthalmology Devices
•21 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (21)
%
| Company | Market Cap | Price |
|---|---|---|
|
Ophthalmology devices and related technologies (ACUVUE contact lenses; TECNIS IOLs) directly produced and sold.
|
$458.89B |
$190.72
-0.67%
|
|
Alcon directly designs, manufactures, and sells ophthalmology devices including Unity VCS, PanOptix Pro IOL, Voyager DSLT, Clareon-based IOLs, LumiThera Valeda system, and STAAR EVO ICLs.
|
$35.64B |
$72.05
-3.44%
|
|
CooperVision eye-care products (daily silicone hydrogel lenses, MiSight, etc.) are ophthalmology devices sold as eye-care medical devices.
|
$14.02B |
$69.75
-0.53%
|
|
Ophthalmology Devices - ophthalmic/vision assistance devices via eSight acquisition.
|
$5.76B |
$25.63
-2.47%
|
|
The company's enVista, LuxLife, and Beyond intraocular lenses and other eye-care implants are ophthalmology devices.
|
$5.06B |
$14.32
-1.45%
|
|
Glaukos directly designs, manufactures, and markets ophthalmology devices, including MIGS implants like the iStent infinite.
|
$4.72B |
$82.56
-5.10%
|
|
Ophthalmology devices in the Bausch Health portfolio through Bausch + Lomb.
|
$2.24B |
$6.05
-4.87%
|
|
Ophthalmology Devices captures devices used in eye care and diagnostics, relevant to National Vision's eye-care operations.
|
$2.02B |
$25.56
-6.37%
|
|
DEXTENZA and intravitreal/ intracameral formulations are ophthalmology devices and related delivery systems.
|
$1.94B |
$12.48
+1.88%
|
|
STAAR primarily designs, manufactures, and sells ophthalmology devices (implantable lenses) used in refractive surgery, categorized under Ophthalmology Devices.
|
$1.32B |
$26.75
-0.26%
|
|
Envision platform targets ophthalmology applications, aligning with ophthalmology devices.
|
$1.18B |
$15.27
-4.59%
|
|
The product includes an intravitreal implant device (drug-delivery implant) used to treat ocular conditions.
|
$956.48M |
$13.90
+4.91%
|
|
VETi wearable imaging device aligns with ophthalmology-focused medical devices.
|
$626.30M |
$11.87
-11.42%
|
|
RxSight directly manufactures and sells Ophthalmology Devices (Light Adjustable Lens system and Light Delivery Device) used in premium cataract surgery.
|
$367.97M |
$9.05
-1.15%
|
|
Company directly manufactures ophthalmology devices (OMNI/OMNIEdge, TearCare, SION Surgical Instrument) used in interventional eye care.
|
$165.45M |
$3.20
-5.04%
|
|
Core product category: ophthalmology devices (surgical laser systems) used for cataract surgery.
|
$140.21M |
$11.89
-1.25%
|
|
Vitargus is an ophthalmology device used in vitreous surgery, placing ABVC in the Ophthalmology Devices category.
|
$50.99M |
$3.04
-7.03%
|
|
Products include ophthalmic/endoscopy devices used in eye care, aligning with ophthalmology devices.
|
$33.16M |
$4.33
|
|
Directly produces ophthalmology device (SCS Microinjector) used for suprachoroidal injection delivery.
|
$20.62M |
$3.98
-8.72%
|
|
NXGEL's hydrogel solutions are used in ophthalmic/eye-care contexts (e.g., adhesives or hydrogel components in ophthalmic procedures), aligning with Ophthalmology Devices.
|
$19.67M |
$2.57
-3.02%
|
|
IRIDEX directly manufactures and markets ophthalmology laser devices and related surgical ophthalmic equipment (e.g., MicroPulse, Endpoint Management, PASCAL/G6 systems).
|
$17.46M |
$1.04
-7.14%
|
Loading industry metrics...
Loading comparison data...
